4D Molecular Therapeutics
NASDAQ: FDMTEmeryville, US · Founded 2015 · Delaware corporation · 8 known investors
Find your way into 4D Molecular Therapeutics
1,039 people in our graph share verified history with the 4D Molecular Therapeutics team — schools, employers, funds. One of them is your warm intro.
Wesley Chanunlockedknows David Schaffer · together at Massachusetts Institute of Technology (overlapped)
×4knows the team · via Massachusetts Institute of Technology
×4knows the team · via Stanford University
knows the team · via Johnson & Johnson
×2knows the team · via University of California, Berkeley
4DMT is a late-stage biotechnology company that develops gene delivery systems and genetic therapeutics targeting specific tissue types for various diseases. The company uses its Therapeutic Vector Evolution platform to design customized vectors for targeted treatment delivery.
Founders & leadership
4D Molecular Therapeutics was founded in 2015 by David Kirn and David Schaffer.
DK
David KirninCo-Founder & CEODavid Kirn is a physician and biotech entrepreneur with expertise in viral vector-based therapeutics and gene therapy. He previously founded and led multiple gene therapy platform companies through clinical development stages and holds a faculty position at UC Berkeley.
DS
David SchafferinCo-Founder, Chief Scientific Advisor, Director2012–2022Director of 4D Molecular Therapeutics, where he leads research in bioengineering and gene therapy, with expertise in signal transduction, gene regulation networks, and viral vector development for therapeutic applications.
TJ
Theresa JankeinChief Of Staff
Board
ST
Sharon TetlowBoard director
MM
Margi McLoughlinBoard director
Investors · 8
Reported raises · per SEC filings
Form D private placements$108.6M disclosed across 3 rounds · 2015–2018
▶$90MraisedSep 2018 · 31 investors · BiotechnologyRule 506(b)
▶$90MraisedSep 2018 · 31 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Theresa JankeExecutive Officer
- Margi McLaughlinDirector
- David Kirn, M.D.Executive Officer, Director
- Peter Francis, M.D.Executive Officer
- Hoyoung Huh, M.D., Ph.D.Director
- Leisa Johnson, Ph.D.Executive Officer
- Charles Theuer, Ph.D.Director
- David Schaffer, Ph.D.,Executive Officer, Director
- Tony YaoDirector
- Offering amount
- $90M
- Amount sold
- $90M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$11.6MraisedOct 2015 · 2 investors · BiotechnologyRule 506(b)
▶$11.6MraisedOct 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David KirnExecutive Officer, Director
- Theresa JankeExecutive Officer
- Sharon TetlowDirector
- Margi McLoughlinDirector
- David SchafferDirector
- Offering amount
- $11.6M
- Amount sold
- $11.6M
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$7MraisedAug 2015 · 1 investors · BiotechnologyRule 506(b)
▶$7MraisedAug 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SchafferDirector
- David KirnExecutive Officer, Director
- Theresa JankeExecutive Officer
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does 4D Molecular Therapeutics do?
- 4DMT is a late-stage biotechnology company that develops gene delivery systems and genetic therapeutics targeting specific tissue types for various diseases. The company uses its Therapeutic Vector Evolution platform to design customized vectors for targeted treatment delivery.
- Who founded 4D Molecular Therapeutics?
- 4D Molecular Therapeutics was founded by David Kirn, David Schaffer in 2015.
- Who are 4D Molecular Therapeutics's investors?
- 4D Molecular Therapeutics's investors include Amzak Health, Berkeley Catalyst, BOLD Longevity, Chiesi Ventures, Pappas Capital, Pfizer Venture Investments, Casdin Capital, Viking Global Investors.
- How much funding has 4D Molecular Therapeutics raised?
- 4D Molecular Therapeutics has disclosed $108.6M raised across 3 rounds.
- Where is 4D Molecular Therapeutics headquartered?
- 4D Molecular Therapeutics is headquartered in Emeryville, US.